Metraipolis › archive › dc_e7d74eaec407

Comparing the Molecular Pharmacological Properties of Existing β-Blockers to Determine the Theoretically Most "Ideal" Anti-Cancer β-Blocker — Europe PMC PMID:41485077

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41485077
DOI: 10.1002/prp2.70214
License (as archived): solo-consultazione
Archived: 2026-11-06T08:21:27.172Z
SHA-256 of the archived text: a9f8fd6c4f593729fdff3bef1126a05285f0dcf35cc774eedc5670988bde185b
Stable URL of this page: https://metraipolis.com/documento/dc_e7d74eaec407

How to cite

Comparing the Molecular Pharmacological Properties of Existing β-Blockers to Determine the Theoretically Most "Ideal" Anti-Cancer β-Blocker — Europe PMC PMID:41485077 — Europe PMC (en), https://europepmc.org/article/MED/41485077 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e7d74eaec407 (Metraipolis archive dc_e7d74eaec407, sha256 a9f8fd6c4f593729fdff3bef1126a05285f0dcf35cc774eedc5670988bde185b)

BibTeX

@misc{dce7d74eaec407,
  title = {Comparing the Molecular Pharmacological Properties of Existing β-Blockers to Determine the Theoretically Most "Ideal" Anti-Cancer β-Blocker — Europe PMC PMID:41485077},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41485077},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e7d74eaec407; sha256 a9f8fd6c4f593729fdff3bef1126a05285f0dcf35cc774eedc5670988bde185b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41485077. Agents can read the archived copy with the MCP tool read_document.